Cargando…
Targeting TRPV1 activity via high‐dose capsaicin in patients with sickle cell disease
Evidence suggests neuropathic pain (NP) develops over time in sickle cell disease (SCD), contributing to a complex, difficult‐to‐treat phenotype, with management based on scant evidence. One characteristic of NP found is hyperalgesia caused by nervous system sensitization, but risk factors for this...
Autores principales: | Glaros, Alexander K., Callaghan, Michael U., Smith, Wally R., Zaidi, Ahmar U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421981/ https://www.ncbi.nlm.nih.gov/pubmed/36051054 http://dx.doi.org/10.1002/jha2.528 |
Ejemplares similares
-
Homozygous sickle cell disease related mortality in Senegal (2011–2020)
por: Seck, Moussa, et al.
Publicado: (2021) -
Sickle cell disease patients with COVID‐19 in Guadeloupe: Surprisingly favorable outcomes
por: Bernit, Emmanuelle, et al.
Publicado: (2022) -
Altered type 1 interferon responses in alloimmunized and nonalloimmunized patients with sickle cell disease
por: Madany, Emaan, et al.
Publicado: (2021) -
Treatment patterns and burden of complications associated with sickle cell disease: A US retrospective claims analysis
por: Manwani, Deepa, et al.
Publicado: (2022) -
Management of acute sickle cell priapism in an African (Togo) pediatric department includes conservative measures and intracavernous epinephrine which is safe and efficacious
por: Guedenon, Koffi Mawuse, et al.
Publicado: (2022)